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According the article “Political will and intersectorality to confront COVID-19 in Cuba”, we need to 
find more recommendations to fight COVID-19(1). The first sequencing of the SARS-CoV-2 virus began 
to be published and stored since December 2019. The data generated from genomic studies, such as 
sequencing, are the basis for studies of molecular epidemiology, population genetics, and studies on 
diversity genetics(2). 
The use of genomes from sequencing creates new areas to study the details of outbreaks such as molecular 
epidemiology (MS), is a hybrid of molecular biology within epidemiological studies. Aiming to establish 
the order of transmission of the pathogen, associate mutations related to its pathogenicity, patterns of 
transmission of pathogens, reservoirs and source of pathogens(3).
Fundamental support for MS is data that comes from high-throughput sequencing technologies (NGS), in 
addition to bioinformatics techniques such as genomics and phylogenetics(4). Likewise, databases of viral 
genomes, bioinformatic networks for phylodynamic analyzes, together with an interactive platform for 
real-time visualization of epidemic outbreaks. These databases are ready to be used to obtain information 
on various epidemiological aspects related to the virus. The objective of this letter is to present a tool 
that allows us to visualize and study epidemics in real-time using DNA sequencing of pathogens.
Nexstrain is a clear example of a current bioinformatics tool for MS, this tool allows the visualization of 
genomes and uses repositories of genomic sequences such as NCBI (www.ncbi.nlm.nih.gov), GISAID (www.
gisaid.org) and ViPR (www.viprbrc.org). The platform performs phylodynamic analysis in addition to 
other tools with phylogenetic inference, temporal dating of ancestral nodes and, probable transmission 
events(5).
Various countries in the world and specifically in the South American region have deposited sequences 
of the SARS-CoV-2 virus in the mentioned databases and are used by Nexstrain for the elaboration of 
phylogenetic trees, as well as a map of their possible spread in the world. A descriptive analysis of 
the molecular epidemiology of SARS-CoV-2 was performed based on the data observed on the Nextrain 
website. The Nexstrain database was accessed to narrate events regarding the possible route of the virus 
since its outbreakin Wuhan, China, settling in Europe and its introduction to South America. 
The results indicate the following at the South American level: Brazil is the first country to reveal the first 
genome of the SARS-CoV-2 virus (accession EPI_ISL_412964) on 02/25/2020, indicating an introduction 
of the virus, from Lombardy, northern Italy. Followed by Argentina (accession EPI_ISL_415700) on 
03/01/2020, Chile (accession EPI_ISL_414577) on 03/03/2020, which are associated with groups from 
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Wuhan, China and Taiwan(6); then Colombia (accession EPI_ISL_418262) on 03/06/2020, Peru (accession 
EPI_ISL_415787) on 03/10/2020, Uruguay (accession EPI_ISL_426479) on 03/19/2020, finally Ecuador 
(accession EPI_ISL_422563) revealed the virus genome on 03/30/2020 to the community. 
In addition, we review the distribution of deposited genomes worldwide (Table 1). Europe exhibits 45 % 
of the total (788), followed by North America with 8,1 % (142), being South America (119) and Africa (89) 
with percentages 6,8 % and 5 % respectively, these being Minor locations represented within the global 
context. Likewise, we observed a significant representation of clades A2a and A1a for both South America 
and the various locations globally, indicating some mutations of the sequenced viruses (Figure 1).
Table 1. Distribution of annotated SARS-CoV-2 genomes 
in Nexstrain globally until May 15, 2020
Origin Number of genomes Clades
Europe 788 A2a, A1a
North-America 142 A2a, B1
Oceania 76 A2a, A1a
Asia 536 A2a, A1a, B
South America 119 A2a, A1a
Africa 89 A2a, A1a
We believe that it is important to focus efforts on knowing and identifying a greater number of SARS-
CoV-2 samples that circulate in South American countries, especially those countries where there is 
only one deposited genome, as in the case of Peru. This will allow us to understand the dynamics of 
transmission of this and the control measures that can be taken to stop the spread of the infection 
and its possible readmissions. On the other hand, comparing its genomes allows us to determine the 
degree of existing genetic diversity, that is, how it is mutating, or if it obtained a recombination 
process, however, there is no mutation associated with its pathogenicity or virulence at the moment.
Figure 1. Phylogenetic tree of the representation of the SARS-CoV-2 virus genomes in South America. Obtained 
from Nexstrain.
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In conclusion, Nexstrain is a tool that provides support for real-time molecular epidemiology surveillance studies, 
being of great help through a visualization platform for epidemiologists, virologists, and political decision-
makers. Brazil has greater representation being the pioneer, however, South America is poorly represented, 
highlighting the European clades that were introduced. Further sequencing studies are recommended in 
patients from South America.
